Founded in 2008, Seventh Sense Biosystems has designed and developed TAP, the world's first push-button blood collection device. It makes the process simple, convenient, and virtually painless. $50 billion is spent annually on diagnostics and consumers are demanding more from the healthcare system. The company aims to create a new standard for blood collection that increases patient compliance with testing orders, leading to faster diagnoses and better outcomes. Future versions of TAP will enable patients to collect their own blood anywhere.
| Date | Amount | Type | Investors | Valuation |
|---|---|---|---|---|
| 08/13/14 | $16,000,000 | Series B |
Flagship Ventures Laboratory Corporation of America Novartis Venture Funds Polaris Partners Siemens Venture Capital | undisclosed |
| 11/18/16 | $10,000,000 | Series C |
Flagship Ventures Laboratory Corporation of America Novartis Venture Funds Polaris Partners | undisclosed |
